C
Health Care

China Jo-Jo Drugstores, Inc.

CJJD
Since

Headquarters:

China

Exchange:

NASDAQ

Industry:

Pharmaceutical Retailers

Number of Employees:

939.00

Current Fiscal Year:

2025

Market Cap:

9.39M

Price per Share:

$1.52

Quarterly Dividend per Share:

Year-to-date Performance:
-16.9399%
Dividend Yield:
%
Price-to-book Ratio:
0.60
Trailing P/E Ratio:
N/A

Price History

Latest Prices

DateOpenHighLowClose
2025-03-031.571.59921.521.52
2025-02-281.621.621.51061.61
2025-02-271.471.621.471.5301
2025-02-261.41081.531.41.53
2025-02-251.631.69881.461.46

China Jo-Jo Drugstores, Inc. operates as a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company offers consultation, examination, and treatment of common ailments by licensed doctors in western medicine and TCM at scheduled hours. In addition, it provides treatment for minor ailments, such as sprains, minor lacerations, and dizziness; acupuncture, therapeutic massage, and cupping services; and minor outpatient surgical treatments, including suturing. Further, it offers OTC drugs and nutritional supplements through its website www.dada360.com, as well as sells products through third-party platforms. Additionally, the company distributes third-party pharmaceutical products to trading companies, as well as cultivates and wholesales herbs used for TCM. It operates pharmacies under the Jiuzhou Grand Pharmacy name. China Jo-Jo Drugstores, Inc. is headquartered in Hangzhou, the People's Republic of China.

Financial Performance

2025 Revenue:0.00

Detailed view of quarterly revenue

2025 Net Income:0.00

Detailed view of quarterly net income

2025 Free Cash Flow:0.00

Overview of free cash flow for the quarter

Annual Revenue Comparison

Compares total annual revenues

Similar Companies

Consumer Discretionary
JD
JD.com, Inc.
JD.com, Inc. operates as a supply chain-based technology and service provider in the People's Republic of China. The company offers computers, communication, and consumer electronics products, as well as home appliances; and general merchandise products comprising food, beverage and fresh produce, baby and maternity products, furniture and household goods, cosmetics and other personal care items, pharmaceutical and healthcare products, industrial products, books, automobile accessories, apparel and footwear, bags, and jewelry. It also provides online marketplace services for third-party merchants; marketing services; and omni-channel solutions to customers and offline retailers, as well as online healthcare services. In addition, the company develops, owns, and manages its logistics facilities and other real estate properties to support third parties; offers asset management services and integrated service platform; leasing of storage facilities and related management services; and engages in online retail business. Further, it provides integrated data, technology, business, and user management industry solutions to support the digitization of enterprises and institutions; and technology-driven supply chain solutions and logistics services. The company was formerly known as 360buy Jingdong Inc. and changed its name to JD.com, Inc. in January 2014. JD.com, Inc. was incorporated in 2006 and is headquartered in Beijing, the People's Republic of China.
47.66B
Market Cap
*Data based on the last 12 months.
Health Care
YI
111, Inc.
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates in two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. The company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangdong, Guangzhou, Tianjin, and Kunshan. It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
417.18M
Market Cap
*Data based on the last 12 months.
Consumer Discretionary
J
Jowell Global Ltd.
Jowell Global Ltd. engages in the online retail of cosmetics, health and nutritional supplements, and household products in China. It offers health and nutritional supplements and foods, such as immune system regulator, bone health, and beauty and beauty supplements products; cosmetics, including lipstick, foundation, cream, eyebrow pencil, makeup remover, lip enamel, eye shadow and liner, and mascara; skin care comprising eye cream and mask, sunscreen and skin cream, moisturizing water, lotion, hand cream, cleansing and face cream, essence, and facial mask; and body care that include body wash, shampoo, hair conditioner, hand sanitizer, essential oil, toothpaste, mouthwash, essential oil soap, and styling gel. The company also provides baby and children, such as lip balm, baby massage oil, moisture cream, shower gel, shampoo, hand sanitizer, baby toothpaste, diaper, and baby soap; washing items, including detergent, washing powder and tablet, washing liquid, kitchen cleaner, soap, and pipe dredger; fragrances comprising traditional herbal lotion, perfume for men and women, fragrant ball, and air purifying box; food that include fruits, vegetables, snacks, roasted sunflower seeds and nuts, biscuits and pastries, health foods, beverages, wines, prepared products, kitchen seasoning, and dry grain and oil. In addition, it offers electronics, such as large electronic, home appliances, kitchen, and cosmetic electronic appliances; apparel, including men and women clothes, shoes, bags, suitcases, and accessories; and household products comprising home textile and decoration, maternal and infant products, kitchenware, and daily life necessities. Further, the company sells its products through retail stores under the Love Home Store, LHH Store, and Juhao Best Choice Store names. It operates through online marketplace that enables third-party sellers to sell their products to company consumers. The company was founded in 2012 and is based in Shanghai, China.
3.80M
Market Cap
*Data based on the last 12 months.
Health Care
C
China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.
0.00
Market Cap
*Data based on the last 12 months.
Health Care
B
BIMI Holdings Inc.
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services; and operates two private hospitals in China. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. BIMI Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York.
0.00
Market Cap
*Data based on the last 12 months.